THE BALANCEhttps://thebalance.clinic/resources/research/oman-addiction-capacity-continuing-care/

Swiss roots. International expertise. Personal care, delivered with privacy and discretion.

THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Privacy and discretion from the first conversation.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Swiss entrepreneur · Founder & CEO

Clinical resource

Oman Is Adding Addiction-Treatment Capacity. What Happens After Discharge?

Oman's new rehabilitation capacity raises a question relevant to families choosing care locally or abroad: who measures recovery after the residential stay?

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

Transition and aftercare

The return home begins before discharge.

01

Continuity plan

A personalized plan is developed before discharge.

02

Clinical handover

Therapeutic, psychiatric, and local care is coordinated.

03

Life context

Risk, sleep, work, relationships, routines, and family remain in view.

Three months of personalized aftercare are included within the current private residential program; format and frequency are confirmed in the individual plan.

A new rehabilitation bed is a tangible investment. Sustained recovery is harder to count. Oman’s expansion of addiction treatment creates a useful moment to ask what happens during care and after a person returns home. For families considering treatment across borders, the comparison should concern complete pathways, not simply local versus international destinations.

Key findings

April 16, 2026: the Ministry of Health announcement opening Al Salwa Hospital in Sohar.

30 beds: capacity described for the first phase.

25 beds: a planned second-phase detoxification department. Planned beds are not confirmed operational capacity.

Several weeks to six months: the described range for individualized rehabilitation programs, with discharge and follow-up coordination. This is not a recommended duration for every patient. [1]

Opened and planned capacity are different measures

Al Salwa Hospital capacity in the April 2026 announcementThirty beds in the first phase; twenty-five planned detoxification beds in the second phase. The hollow second bar denotes planned rather than confirmed operational capacity. Both bars begin at zero.Beds described by the Ministry of Health, April 2026First phase30Planned second phase250102030

This is a capacity comparison, not a patient count or clinical result. The figures should not be added and labeled current operating capacity. Source: Ministry of Health. [1]

New facilities matter because they describe a change in provision. The next evidence should connect that provision with the people assessed, admitted, treated, and followed afterward.

A bed count alone cannot establish symptom improvement, access to appropriate interventions, or the durability of recovery.

The same questions should apply to private services

A new residence, a larger team, or more appointments may change availability and experience. None automatically quantifies clinical benefit.

Families should apply the standard consistently. Public services should not face demanding outcome questions while an expensive private program is evaluated only through testimonials.

Ask how the proposed setting fits assessed needs, what is delivered, and how progress is reviewed. The facilities are part of the offer, not a substitute for the clinical rationale.

Continuing care has evidence, but effects vary

A 2021 review found support for continuing care in substance-use treatment, while describing generally modest pooled benefits and variation between interventions. More active engagement and longer continuing-care approaches sometimes produced more consistent results. [2]

The review does not establish one ideal program for everybody or evaluate an Omani hospital. Evidence for a treatment component also does not automatically validate an entire commercial package.

A provider should distinguish what draws on established research from what has been evaluated in its own patients. An individualized plan can be clinically appropriate without a definitive comparative trial, provided the evidence is described honestly.

Standards organize questions, not country rankings

WHO and UNODC’s international standards describe evidence-based, ethical treatment systems across different needs and settings. They are not a league table of countries or a certificate guaranteeing a provider’s results. [3]

Use such frameworks to ask better questions about assessment, treatment, consent, and continuity. They should not replace the individual clinical decision or become a general claim of superiority.

Five stages a useful recovery report should distinguish
StageUseful measureLimit
AvailabilityOperational capacity and eligibilityDoes not establish care received
AccessAssessment and treatment-start intervalsNot clinical improvement
EngagementStarts, completions, transfers, departuresAn ending may be a planned transfer
DischargeHealth measures and patient goalsNot evidence of durability
Follow-upLater health, functioning, and treatmentRespondents may not represent all admissions

Ownership is not an effectiveness comparison

The Al Salwa announcement describes a partnership involving public bodies, a healthcare company, and supporting funding. That identifies an organizational model, not proof that one ownership structure produces better recovery. [1]

A fair comparison needs compatible patients, interventions, and outcomes. Services may differ in severity, substances involved, co-occurring conditions, and eligibility.

Costs also need a defined scope. A fee may exclude travel, continuing care, or unpaid family support. A legitimate preference for privacy or convenience does not itself demonstrate greater effectiveness.

Missing follow-up belongs before the success claim

A report should identify everyone it tried to contact and how many supplied an outcome. A favorable result among respondents is not automatically the result among everybody admitted.

Missing observations are unknown, not automatic relapse. A patient moving between countries may have transferred to another clinician. Where consent and data arrangements allow, that differs from completely unknown status.

Reports should also describe how outcomes were measured and what care continued. A return to treatment could indicate deterioration, timely help-seeking, or planned maintenance. The clinical context changes its meaning.

What can actually be compared in Oman now?

The announcement supports comparison between opened and planned phases. It does not establish a national addiction prevalence estimate, a citizen-versus-expatriate outcome, or a ranking of treatment destinations.

The Ministry’s Al Masarra Hospital information separately describes psychiatric, addiction, and community services, including support after hospital treatment. That provides service context, not a comparable longitudinal patient dataset. [4]

The useful next study would follow a defined group through care transitions. A national dataset, provider report, and original survey could each contribute, but should keep their separate populations and purposes.

International treatment should work after the flight home

Families considering care outside Oman may value specialist expertise, language, privacy, or time away from regular responsibilities. Those priorities should be discussed without assuming overseas care is better.

Travel can change who reviews medication, arranges follow-up, or responds to deteriorating symptoms. Resolve those responsibilities before admission where possible.

For a business owner, returning home may also mean resuming decisions and family responsibilities. For another patient, work may not be an immediate goal. Outcome measurement should allow both rather than define recovery as the fastest return to a demanding role.

Compare the complete pathway

Proposed questions for treatment in Oman and abroad
DecisionInformation to obtain
Clinical suitabilityAssessment, scope, exclusions, and co-occurring care
ContinuityNamed responsibility for handover and review
PrivacyPurpose and consent for information sharing
ProgressBaseline measures, review dates, and patient goals
EvidenceObserved outcomes, eligible sample, and missing follow-up
Practical accessLanguage, travel, and receiving appointments

This is a proposed discussion framework, not a validated clinic rating or an evaluation of Al Salwa Hospital. THE BALANCE should answer the same questions about its own pathway.

A recommendation to contact a professional differs from an accepted handover. The patient should know which arrangements are confirmed and which remain suggestions.

Duration needs a clinical reason

The range of several weeks to six months in the announcement describes individualized programs. It does not establish that longer stays always work better or prescribe a duration for a particular person.

Ask which goals justify the initial plan and what would prompt adjustment. A large budget should not replace reassessment, just as a short package should not force an unsuitable end to needed care.

Where clinical responsibilities cross countries, verify professional requirements and realistic access rather than rely on a broad worldwide-aftercare promise.

What the evidence cannot tell us

No source here establishes a recovery rate for the newly announced facility or a special outcome for HNW Omani patients. The opening is a service development, not a controlled trial. The continuing-care literature supports defined approaches rather than every program carrying that label.

The bottom line

The outcome is a life, not a bed-day. New capacity deserves attention, and the next reporting step should connect it to appropriate treatment and longer-term progress. For families, the decisive question is who remains involved and what happens when the setting changes.

For journalists

Key distinction: thirty beds were described in the opened first phase; twenty-five detoxification beds were planned, not confirmed operational.

Outcome caveat: capacity and program duration do not establish recovery.

Suggested attribution: THE BALANCE analysis of Oman’s service announcement and continuing-care evidence.

Methodology and sources

This narrative analysis preserves the distinction between completed and planned phases in the Arabic ministry announcement. It uses no patient records or proprietary outcomes. The reporting framework is proposed analysis, not observed service performance.

  1. Oman Ministry of Health. Al Salwa Hospital opening. April 16, 2026. Arabic.
  2. McKay. Impact of Continuing Care on Recovery From Substance Use Disorder. 2021.
  3. WHO and UNODC. International Standards for the Treatment of Drug Use Disorders. 2020.
  4. Oman Ministry of Health. Al Masarra Hospital service information.
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care